Shuning Chen

ORCID: 0000-0002-3824-4815 · 6 papers in corpus
review 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1702273

Ovarian cancer, particularly epithelial ovarian cancer (EOC), is the most aggressive and lethal gynecologic malignancy, necessitating the development of innovative and potent therapies to improve its prognosis. Human polo-like kinase 1 (PLK…

lab-animal 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1520771

OBJECTIVE: Chronic inflammation is a key contributor to carcinogenesis, progression, and chemoresistance in ovarian cancer, making inflammatory pathways a logical therapeutic target for the treatment of this disease. Sulindac, a commonly us…

other 2023
International journal of medical sciences ·doi:10.7150/ijms.79516

Endometriosis is a hormone-dependent disease in women of reproductive age and seriously affects women's health. To analyze the involvement of sex hormone receptors in endometriosis development, we performed bioinformatics analysis using fou…

lab-animal 2023
In vivo (Athens, Greece) ·doi:10.21873/invivo.13356

BACKGROUND/AIM: Endometriosis is an estrogen-dependent disease characterized by the ectopic implantation and growth of endometrial tissue outside the uterus. Endometrial stromal cells (ESCs) play a crucial role in the pathogenesis of endome…

review 2023
Anticancer research ·doi:10.21873/anticanres.16515

Ovarian clear cell carcinomas (OCCCs) are a subtype of ovarian epithelial tumors that arise from the malignant transformation of endometriosis (EMs). These tumors have distinctive molecular features, high malignant potential, low sensitivit…

other 2023
Frontiers in medicine ·doi:10.3389/fmed.2023.1132676

INTRODUCTION: Endometriosis (EM) is an aggressive, pleomorphic, and common gynecological disease. Its clinical presentation includes abnormal menstruation, dysmenorrhea, and infertility, which seriously affect the patient's quality of life.…